ClinConnect ClinConnect Logo
Search / Trial NCT05169047

Subthreshold SCS or BMT

Launched by MOENS MAARTEN · Dec 22, 2021

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking to find out whether a treatment called subthreshold spinal cord stimulation (SCS) is more effective than the best medical treatment (BMT) for patients suffering from a condition known as Persistent Spinal Pain Syndrome Type II (PSPS-T2). The main goal is to see if patients receiving subthreshold SCS experience better overall improvements in their pain and quality of life after six months. Additionally, the study will explore if this treatment helps patients manage their pain better, return to work, and reduce their need for pain medication.

To participate in this trial, individuals must be at least 18 years old and have experienced chronic pain from PSPS-T2 for at least six months, with a pain level of 4 or higher on a scale of 0 to 10. They should also be eligible for the subthreshold SCS treatment. Participants will be required to attend study visits and follow the study guidelines closely. It's important to know that those with certain medical conditions or psychiatric disorders may not be eligible for this trial. If you're interested, this study could provide valuable insights into new treatment options for managing chronic pain.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Persistent Spinal Pain Syndrome Type II (PSPS-T2)
  • Chronic pain as a result of PSPS-T2 that exists for at least 6 months with a pain intensity of at least 4/10 on the Numeric Rating Scale, refractory to conservative treatment.
  • PSPS-T2 patients eligible for subthreshold SCS
  • Age \> 18 years
  • Patient has been informed of the study procedures and has given written informed consent
  • Patient willing to comply with study protocol including attending the study visits
  • Exclusion Criteria:
  • Expected inability of patients to receive or properly operate the spinal cord stimulation system
  • Evidence of an active psychiatric disorder
  • Suffering from another chronic illness characterised by chronic generalized widespread pain (e.g. rheumatoid arthritis, fibromyalgia, chronic fatigue syndrome, scleroderma).
  • Pregnancy

About Moens Maarten

Moens Maarten is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes. With a focus on innovative therapies and rigorous scientific methodologies, the organization collaborates with leading institutions and healthcare professionals to conduct high-quality clinical trials. Moens Maarten emphasizes ethical standards, patient safety, and regulatory compliance throughout the research process, ensuring that studies are conducted with integrity and transparency. Their mission is to contribute to the development of effective treatments that address unmet medical needs while fostering a culture of collaboration and excellence in clinical research.

Locations

Jette, , Belgium

Turnhout, , Belgium

Roeselare, , Belgium

Hasselt, , Belgium

Mechelen, , Belgium

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials